Desktop Site
|
24 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
S&P
BSE SENSEX
73,852.94
+114.49
+0.16 %
Corporate Announcement
Security Code
524715
Company
Sun Pharmaceutical Industries Ltd
Exchange Received Time
17/03/2017 14:55:23
Exchange Disseminated Time
17/03/2017 14:55:30
Time Taken
00:00:07
Acquisition |
3/17/2017 2:55:23 PM
This is to inform you that one of the indirect subsidiaries of the Company namely, Taro Pharmaceuticals Inc. (Canada) has entered into an agreement to acquire all of the issued and outstanding shares of Thallion Pharmaceuticals Inc., a Canadian pharmaceutical corporation. The disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Clause A (1) of Part A , Schedule III of the aforesaid regulations, is attached as per 'Annexure A'.
Attachment
<< Back
Recently Viewed